Abstract
We describe the differentiation of human embryonic stem (hES) cells into endothelial cells using a scalable two-dimensional method that avoids an embryoid-body intermediate. After transplantation into severe combined immunodeficient (SCID) mice, the differentiated cells contributed to arborized blood vessels that integrated into the host circulatory system and served as blood conduits for 150 d.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Itskovitz-Eldor, J. et al. Mol. Med. 6, 88–95 (2000).
Chadwick, K. et al. Blood 102, 906–915 (2003).
Kaufman, D.S., Hanson, E.T., Lewis, R.L., Auerbach, R. & Thomson, J.A. Proc. Natl. Acad. Sci. USA 98, 10716–10721 (2001).
Vodyanik, M.A., Bork, J.A., Thomson, J.A. & Slukvin, I.I. Blood 105, 617–626 (2005).
Levenberg, S., Golub, J.S., Amit, M., Itskovitz-Eldor, J. & Langer, R. Proc. Natl. Acad. Sci. USA 99, 4391–4396 (2002).
Barker, J.E. Dev. Biol. 18, 14–29 (1968).
Brotherton, T.W., Chui, D.H., Gauldie, J. & Patterson, M. Proc. Natl. Acad. Sci. USA 76, 2853–2857 (1979).
Carmeliet, P. Nat. Med. 9, 653–660 (2003).
Peichev, M. et al. Blood 95, 952–958 (2000).
Asahara, T. et al. Science 275, 964–967 (1997).
Gehling, U.M. et al. Blood 95, 3106–3112 (2000).
Koike, N. et al. Nature 428, 138–139 (2004).
Kashiwagi, S. et al. J. Clin. Invest. 115, 1816–1827 (2005).
Acknowledgements
This study was partially supported by National Institutes of Health grants K01DK064696 (Z.W.), P20RR018789 (Z.W.), P01CA80124 (R.K.J., D.F.), R01CA96915 (D.F.) and R01CA115767 (R.K.J.) and the Harvard Stem Cell Institute.
Author information
Authors and Affiliations
Contributions
Z.Z.W. designed, coordinated and performed research, analyzed data and wrote the manuscript; P.A. and T.C. performed research, analyzed data and wrote the manuscript; Y.S., L.M.D., H.B., M.A. performed research; D.F. provided useful discussions and wrote the manuscript; R.K.J. and D.T.S. designed and coordinated research, analyzed data and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Schematic representation of hESC culture. (PDF 108 kb)
Supplementary Fig. 2
RT-PCR analysis of CD31 and GATA-2 gene expression. (PDF 59 kb)
Supplementary Fig. 3
FACS analysis of CD34+ cells after magnetic bead selection. (PDF 58 kb)
Supplementary Fig. 4
Differentiation of hESCs with three batches of FBS. (PDF 79 kb)
Supplementary Fig. 5
Differentiation of hESCs in serum-free media. (PDF 62 kb)
Supplementary Fig. 6
Cell number of adherent and suspension cells. (PDF 50 kb)
Supplementary Fig. 7
Hematopoietic differentiation of hESC-derived CD34+ cells. (PDF 75 kb)
Supplementary Fig. 8
Gene expression analysis of hESC-derived endothelial cells by RT-PCR. (PDF 256 kb)
Supplementary Video 1
Blood flow in HESC-derived engineered vessels. (MOV 719 kb)
Supplementary Video 2
Three-dimensional image of HESC-derived engineered vessels and extracellular matrix. (MOV 283 kb)
Rights and permissions
About this article
Cite this article
Wang, Z., Au, P., Chen, T. et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25, 317–318 (2007). https://doi.org/10.1038/nbt1287
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1287